Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
—
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
5 Years
—
—
50%
—
—
Never
—
5 Years
Score—
Net Growth—
Net Trend50%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Explore the 2021 public Archive ranking →
Where Emergent Biosolutions Inc has ranked, year by year
Measure
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- EBS
2012: 51.9% · 2021: 28.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-01 | $ 6.37 | — |
1 Year2025-10-01 | $ 9.19 | -30.69% |
5 Years2021-10-01 | $ 55.01 | -88.42% |
10 Years2016-09-30 | $ 31.53 | -79.80% |
All Time2006-11-15 | $ 10.40 | -38.75% |
| Period | Last Price2026-10-01 | 1 Year2025-10-01 | 5 Years2021-10-01 | 10 Years2016-09-30 | All Time2006-11-15 |
|---|---|---|---|---|---|
| Price | $ 6.37 | $ 9.19 | $ 55.01 | $ 31.53 | $ 10.40 |
| Return | — | -30.69% | -88.42% | -79.80% | -38.75% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 139M | ||
| 2025 | $ 742M | $ 52M | $ 205M |
| 2024 | $ 1.04B | -$ 190M | $ 99M |
| 2023 | $ 1.04B | -$ 760M | $ 111M |
| 2022 | $ 1.11B | -$ 211M | $ 642M |
| 2021 | $ 1.77B | $ 219M | $ 576M |
| 2020 | $ 1.57B | $ 305M | $ 621M |
| 2019 | $ 1.10B | $ 54M | $ 168M |
| 2018 | $ 782M | $ 62M | $ 112M |
| 2017 | $ 560M | $ 82M | $ 178M |
| 2016 | $ 488M | $ 51M | $ 271M |
| 2015 | $ 489M | $ 62M | $ 312M |
| 2014 | $ 404M | $ 36M | $ 280M |
| 2013 | $ 312M | $ 31M | $ 179M |
| 2012 | $ 281M | $ 23M | $ 141M |
| 2011 | $ 273M | $ 23M | $ 145M |
| 2010 | $ 286M | $ 51M | $ 171M |
| 2009 | $ 234M | $ 31M | $ 102M |
| 2008 | $ 178M | $ 20M | $ 91M |
| 2007 | $ 182M | $ 22M | $ 105M |
| IPO2006 | $ 152M | $ 22M | $ 76M |
Emergent Biosolutions Inc fundamental performance
Across Emergent Biosolutions Inc's full reported history, from 2006 to 2025, revenue grew from $ 152M to $ 742M and net income grew from $ 22M to $ 52M. Revenue increased in 63% of the years measured; net income in 58%.
Membership
Continue EBS’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,813 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
